Compare Nuvalent Inc (NUVL) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs Tilray Brands Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Tilray Brands Inc trades at $4.24 (market cap $524.07M). The key difference: Nuvalent Inc is far larger — about 18.7× Tilray Brands Inc's market cap, and Nuvalent Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| NUVL | TLRY | |
|---|---|---|
Market Cap | $9.81B | $524.07M |
Sector | Technology | Health |
52-Week High | $123.96 | $21.00 |
52-Week Low | $72.16 | $4.23 |
Enterprise Value | $8.52B | $621.22M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
